» Articles » PMID: 15907940

Neurological Soft Signs, Clinical Symptoms and Treatment Reactivity in Patients Suffering from First Episode Schizophrenia

Overview
Journal J Psychiatr Res
Specialty Psychiatry
Date 2005 May 24
PMID 15907940
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: (a) To investigate the correlation between clinical symptoms and neurological soft signs in patients suffering from their first episode of schizophrenia and (b) to examine the relationship between soft signs and the reactivity of first episode treatment.

Methods: The trial included 92 male patients undergoing a first episode of schizophrenia. The clinical symptoms of the patients were rated on the positive and negative syndrome scale (PANSS). The PANSS scale was used to provide a measure for three syndromes: psychomotor poverty, disorganisation, and reality distortion. Neurological soft signs were assessed with the help of the neurological evaluation scale.

Results: The findings corroborated significant positive correlations between soft neurological signs on the one hand and negative symptoms and reduced treatment response on the other.

Conclusion: Our study of the population of patients with first episode schizophrenia has corroborated the findings of those trials that found a correlation between neurological soft signs and the negative symptomatic dimension of schizophrenia. Another finding of the trial is that neurological soft signs were associated with poorer response to treatment of the first episode of schizophrenia.

Citing Articles

The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia.

Petrescu C, Papacocea I, Vilciu C, Mihalache O, Vlad D, Marian G Biomedicines. 2022; 10(11).

PMID: 36428507 PMC: 9687986. DOI: 10.3390/biomedicines10112939.


Default Mode Network Aberrant Connectivity Associated with Neurological Soft Signs in Schizophrenia Patients and Unaffected Relatives.

Galindo L, Berge D, Murray G, Mane A, Bulbena A, Perez V Front Psychiatry. 2018; 8:298.

PMID: 29375404 PMC: 5767074. DOI: 10.3389/fpsyt.2017.00298.


Neurological Soft Signs in Schizophrenia: An Update on the State- versus Trait-Perspective.

Bachmann S, Schroder J Front Psychiatry. 2018; 8:272.

PMID: 29375401 PMC: 5766896. DOI: 10.3389/fpsyt.2017.00272.


Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders.

Peralta V, Cuesta M Schizophr Bull. 2017; 43(5):956-971.

PMID: 28911050 PMC: 5581892. DOI: 10.1093/schbul/sbx089.


A Study of Soft Neurological Signs and Its Correlates in Drug-Naive Patients with First Episode Psychosis.

Gunasekaran V, Venkatesh V, Asokan T Indian J Psychol Med. 2016; 38(5):408-413.

PMID: 27833222 PMC: 5052952. DOI: 10.4103/0253-7176.191393.